Arcutis Biotherapeutics, Inc. (ARQT)
NASDAQ: ARQT · Real-Time Price · USD
25.54
-1.46 (-5.41%)
Nov 6, 2026, 4:00 PM EST - Market closed
Arcutis Biotherapeutics Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| TD Cowen | TD Cowen | Buy Maintains $35 → $40 | Buy | Maintains | $35 → $40 | +56.62% | Nov 5, 2026 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $38 | Buy | Maintains | $38 | +48.79% | Nov 5, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $40 | Buy | Reiterates | $40 | +56.62% | Nov 5, 2026 |
| Guggenheim | Guggenheim | Buy Reiterates $38 → $44 | Buy | Reiterates | $38 → $44 | +72.28% | Oct 19, 2026 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Initiates $48 | Buy | Initiates | $48 | +87.94% | Oct 15, 2026 |
| Needham | Needham | Buy Reiterates $40 | Buy | Reiterates | $40 | +56.62% | Aug 6, 2026 |
Unknown Analyst Jefferies No rating | Jefferies | Buy Maintains $35 | Buy | Maintains | $35 | +37.04% | Jul 9, 2026 |